📊 CYAND Key Takeaways
Is Cyanotech Corp. (CYAND) a Good Investment?
Cyanotech exhibits deteriorating financial health with persistent operating losses, negative free cash flow, and weak liquidity despite modest revenue growth. The company is burning cash while struggling to maintain profitability, indicating fundamental operational challenges in its medicinal chemicals and botanical products business.
Cyanotech shows modest top-line growth and improved net income year over year, but the business remains unprofitable with negative operating income, negative free cash flow, and weak returns on capital. Financial health is fragile, with minimal cash, a quick ratio of 0.30x, and negative interest coverage, which limits flexibility if operating performance does not improve materially.
Why Buy Cyanotech Corp. Stock? CYAND Key Strengths
- Positive revenue growth of 5.0% YoY shows market demand persistence
- Reasonable gross margin of 32.6% indicates production efficiency at unit level
- Moderate leverage with debt-to-equity ratio of 0.52x provides some financial flexibility
- Revenue grew 5.0% year over year, indicating some underlying demand resilience
- Gross margin of 32.6% suggests the core product base retains reasonable unit economics before overhead and financing costs
- Debt/equity of 0.52x is not extreme on its own, leaving some balance sheet capacity if profitability improves
CYAND Stock Risks: Cyanotech Corp. Investment Risks
- Negative operating cash flow of -220K and free cash flow of -306K indicate unsustainable burn rate
- Critical liquidity concerns with current ratio of 1.00x and quick ratio of 0.30x; cash position of only 649K insufficient for ongoing operations
- Persistent net losses (-925K) and negative interest coverage of -1.6x suggest inability to service debt from operations
- Operating margin of -4.4% indicates core business is unprofitable despite gross margin strength, suggesting overhead burden and operational inefficiency
- The company remains loss-making, with negative operating margin, negative net margin, and negative ROE/ROA
- Liquidity is tight, with only $649K in cash, a current ratio of 1.00x, and a quick ratio of 0.30x
- Negative operating cash flow and negative interest coverage raise concern about sustainability without better earnings or external funding
Key Metrics to Watch
- Operating cash flow trend - must turn positive to ensure viability
- Cash balance and runway - critical given current burn rate
- Operating margin improvement - path to profitability at EBITDA level
- Revenue growth sustainability - whether 5% growth can accelerate
- Operating margin and operating cash flow
- Cash balance and quick ratio
Cyanotech Corp. (CYAND) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Cyanotech Corp. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
CYAND Profit Margin, ROE & Profitability Analysis
CYAND vs Materials Sector: How Cyanotech Corp. Compares
How Cyanotech Corp. compares to Materials sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Cyanotech Corp. Stock Overvalued? CYAND Valuation Analysis 2026
Based on fundamental analysis, Cyanotech Corp. shows some fundamental concerns relative to the Materials sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Cyanotech Corp. Balance Sheet: CYAND Debt, Cash & Liquidity
CYAND Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Cyanotech Corp.'s revenue has declined by 25% over the 5-year period, indicating business contraction. The most recent EPS of $0.35 reflects profitable operations.
CYAND Revenue Growth, EPS Growth & YoY Performance
CYAND Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2025 | $5.8M | $1.0K | $0.00 |
| Q1 2025 | $5.8M | -$926.0K | N/A |
| Q3 2024 | $5.6M | -$224.0K | N/A |
| Q2 2024 | $5.8M | -$797.0K | $-0.13 |
| Q1 2024 | $5.1M | -$1.2M | $-0.17 |
| Q3 2023 | $5.6M | $386.0K | $0.06 |
| Q2 2023 | $5.2M | -$797.0K | $-0.13 |
| Q1 2023 | $5.1M | -$472.0K | $-0.08 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Cyanotech Corp. Dividends, Buybacks & Capital Allocation
CYAND SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Cyanotech Corp. (CIK: 0000768408)
📋 Recent SEC Filings
❓ Frequently Asked Questions about CYAND
What is the AI rating for CYAND?
Cyanotech Corp. (CYAND) has a Combined AI Rating of SELL from Claude (SELL) and ChatGPT (SELL) with 84% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are CYAND's key strengths?
Claude: Positive revenue growth of 5.0% YoY shows market demand persistence. Reasonable gross margin of 32.6% indicates production efficiency at unit level. ChatGPT: Revenue grew 5.0% year over year, indicating some underlying demand resilience. Gross margin of 32.6% suggests the core product base retains reasonable unit economics before overhead and financing costs.
What are the risks of investing in CYAND?
Claude: Negative operating cash flow of -220K and free cash flow of -306K indicate unsustainable burn rate. Critical liquidity concerns with current ratio of 1.00x and quick ratio of 0.30x; cash position of only 649K insufficient for ongoing operations. ChatGPT: The company remains loss-making, with negative operating margin, negative net margin, and negative ROE/ROA. Liquidity is tight, with only $649K in cash, a current ratio of 1.00x, and a quick ratio of 0.30x.
What is CYAND's revenue and growth?
Cyanotech Corp. reported revenue of $12.8M.
Does CYAND pay dividends?
Cyanotech Corp. does not currently pay dividends.
Where can I find CYAND SEC filings?
Official SEC filings for Cyanotech Corp. (CIK: 0000768408) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is CYAND's EPS?
Cyanotech Corp. has a diluted EPS of $-0.13.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is CYAND a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Cyanotech Corp. has a SELL rating with 84% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is CYAND stock overvalued or undervalued?
Valuation metrics for CYAND: ROE of -11.5% (sector avg: 14%), net margin of -7.2% (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
Should I buy CYAND stock in 2026?
Our dual AI analysis gives Cyanotech Corp. a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is CYAND's free cash flow?
Cyanotech Corp.'s operating cash flow is $-220.0K, with capital expenditures of $86.0K. FCF margin is -2.4%.
How does CYAND compare to other Materials stocks?
Vs Materials sector averages: Net margin -7.2% (avg: 10%), ROE -11.5% (avg: 14%), current ratio 1.00 (avg: 1.6).